Envista Holdings's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Envista Holdings's ROA in the second quarter of 2026?
Envista Holdings Corporation achieved a return on average assets (ROA) of 1.7 % in its second quarter of 2026, this is above NVST's average return on assets of -1.07%.
Envista Holdings Corporations assets during the 12 months ending in the second quarter of 2026 are valued at $5 billion

ROA has improved compared to 1.22% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 195 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 03 2026 quarter, so far to 2110, from total ROA ranking in the first quarter of 2026 at 2631.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 26 2025) III. Quarter	(Jun 27 2025) II. Quarter
Y / Y Total Assets Change	2.23 %	4.65 %	9 %	2.34 %	3.93 %
Y / Y Net Income Change	103.41 %	115 %	2641.67 %	-	-
Net Income (TTM) in million	95	68	47	15	54
Return On Assets (TTM)	1.7 %	1.22 %	0.85 %	0.28 %	1 %
NVST's Total Ranking	# 2110	# 2631	# 2486	# 2182	# 3635
Total Assets (TTM) in million	5,648	5,578	5,679	5,496	5,525
Seq. Total Assets Change	1.25 %	-1.78 %	3.33 %	-0.51 %	3.65 %
Seq. Net Income Change	38.76 %	17.63 %	-	-	46.67 %

NVST's 5 Years Annual ROA >> Back to NVST Management Effectiveness >> Compare NVST ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 61
Sector	# 196
Overall	# 1898

Return On Assets Statistics
High	Average	Low
5.53 %	-1.07 %	-22.18 %
(Oct 01 2021)		(Sep 27 2024)

Financial Statements
Envista Holdings's Assets	$ 5,648 million	NVST's Balance sheet
Envista Holdings's Income	$ 54 million	Quarterly NVST's Income Statement
NVST's Income by Division		See NVST's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	9 %	-19.62 %	0.36 %	0.17 %	-3.95 %
Total Assets in million	5,679	5,210	6,482	6,459	6,447
Y / Y Net Income Change	-	-	-	-28.6 %	922.52 %
Net Income in million	47	-1,119	-100	243	341
Annual Return On Assets	0.83 %	-21.47 %	-1.55 %	3.76 %	5.28 %

NVST's 5 Years Annual ROA >> Back to NVST Management Effectiveness >> Compare NVST ROA to its Competitors

Comment on NVST's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 0.83 % compared to prior year, due to annual net income growth of % to $47.00 million, while value of Envista Holdings's overall assets grew just by 9 % to $5,679.00 million, compared to $5,679.00 a year before.

More Return On Assets Ratios
NVST's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NVST's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NVST's Competitors
Subscribers only: Roa for Envista Holdings's Suppliers
Subscribers only: Return On Assets for NVST's Customers

You may also want to know
NVST's Roi	NVST's Inventory Turnover Ratio	NVST's Growth Rates	NVST's Dividend Comparisons
	NVST's Profitability Ratios	NVST's Asset Turnover Ratio	NVST's Dividend Growth
NVST's Roe	NVST's Valuation Ratios	NVST's Financial Strength Ratios	NVST's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 03 2026, within Healthcare Sector	ROA
The Cooper Companies Inc	4.57 %
IMPACT BIOMEDICAL INC.	4.47 %
Nrc Health	4.31 %
Cadre Holdings inc	4.29 %
The Pennant Group Inc	4.14 %
U S Physical Therapy Inc	4.08 %
Haemonetics Corporation	3.99 %
Henry Schein Inc	3.79 %
Integer Holdings Corporation	3.76 %
Zimmer Biomet Holdings Inc	3.51 %
Ardent Health Inc	3.22 %
Community Health Systems Inc	3.17 %
Vaso Corporation	2.92 %
Collegium Pharmaceutical Inc	2.72 %
National Vision Holdings Inc	2.53 %
Conmed Corporation	2.44 %
Merck and Co Inc	2.42 %
Privia Health Group Inc	2.41 %
Lifestance Health Group Inc	2.33 %
Bio rad Laboratories Inc	2.21 %
Pfizer Inc	2.12 %
Mimedx Group Inc	1.99 %
Revvity Inc	1.97 %
Alkermes Plc	1.96 %
Becton Dickinson And Company	1.77 %
Teva Pharmaceutical Industries Limited	1.77 %
Immucell Corporation	1.76 %
Envista Holdings Corporation	1.69 %
Atricure Inc	1.62 %
Black Hawk Acquisition Corporation	1.56 %

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.